Factors affecting individual response Response to AHK-Cu varies substantially between individuals
One of the primary reasons individuals opt for B12 IM injections is to address B12 deficiency, which can lead to symptoms such as fatigue, weakness, difficulty concentrating, and neurological issues

Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption

A 42-year-old woman developed an immediate reaction to intramuscular cyanocobalamin B12, despite positive intradermal testing
This treatment can also promote healthier hair, skin, and nails
If you experience unusual symptoms after the injection, contact your provider promptly